Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

被引:123
作者
McMillan, D. J. [1 ]
Dreze, P. -A. [2 ]
Vu, T. [1 ]
Bessen, D. E. [3 ]
Guglielmini, J. [4 ,5 ]
Steer, A. C. [6 ,7 ]
Carapetis, J. R. [8 ]
Van Melderen, L. [2 ]
Sriprakash, K. S. [1 ]
Smeesters, P. R. [1 ,2 ,7 ]
机构
[1] Queensland Inst Med Res, Bacterial Pathogenesis Lab, Brisbane, Qld 4006, Australia
[2] Univ Libre Brussels, Lab Genet & Physiol Bacterienne, Inst Biol & Med Mol, Fac Sci, B-6041 Gosselies, Belgium
[3] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA
[4] Inst Pasteur, Dept Genomes & Genet, Paris, France
[5] CNRS, UMR3525, Paris, France
[6] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Ctr Int Child Hlth, Melbourne, Vic, Australia
[7] Murdoch Children Res Inst, Melbourne, Vic, Australia
[8] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
Epidemiology; M protein; Streptococcus pyogenes; typing; vaccine; virulence; C-REPEAT REGION; VACCINE DEVELOPMENT; GENETIC DIVERSITY; TANDEM REPEATS; EMM TYPES; PYOGENES; INFECTIONS; PROTECTION; CANDIDATE; SEQUENCES;
D O I
10.1111/1469-0691.12134
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Group A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine antigen, and constitutes the basis for strain typing (emm-typing). Although >200 emm-types are characterized, structural data were obtained from only a limited number of emm-types. We aim to evaluate the sequence diversity of near-full-length M proteins from worldwide sources and analyse their structure, sequence conservation and classification. GAS isolates recovered from throughout the world during the last two decades underwent emm-typing and complete emm gene sequencing. Predicted amino acid sequence analyses, secondary structure predictions and vaccine epitope mapping were performed using MUSCLE and Geneious software. A total of 1086 isolates from 31 countries were analysed, representing 175 emm-types. emm-type is predictive of the whole protein structure, independent of geographical origin or clinical association. Findings of an emm-type paired with multiple, highly divergent central regions were not observed. M protein sequence length, the presence or absence of sequence repeats and predicted secondary structure were assessed in the context of the latest vaccine developments. Based on these global data, the M6 protein model is updated to a three representative M protein (M5, M80 and M77) model, to aid in epidemiological analysis, vaccine development and M protein-related pathogenesis studies.
引用
收藏
页码:E222 / E229
页数:8
相关论文
共 30 条
[1]   Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein [J].
Bauer, Michelle J. ;
Georgousakis, Melina M. ;
Vu, Therese ;
Henningham, Anna ;
Hofmann, Andreas ;
Rettel, Mandy ;
Hafner, Louise M. ;
Sriprakash, Kadaba S. ;
McMillan, David J. .
VACCINE, 2012, 30 (12) :2197-2205
[2]  
BESSEN D, 1990, J IMMUNOL, V145, P1251
[3]   Tissue tropisms in group A streptococcal infections [J].
Bessen, Debra E. ;
Lizano, Sergio .
FUTURE MICROBIOLOGY, 2010, 5 (04) :623-638
[4]   Molecular basis of group A streptococcal virulence [J].
Bisno, AL ;
Brito, MO ;
Collins, CM .
LANCET INFECTIOUS DISEASES, 2003, 3 (04) :191-200
[5]   The global burden of group A streptococcal diseases [J].
Carapetis, JR ;
Steer, AC ;
Mulholland, EK ;
Weber, M .
LANCET INFECTIOUS DISEASES, 2005, 5 (11) :685-694
[6]   Pathogenesis of group A streptococcal infections [J].
Cunningham, MW .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) :470-+
[7]   New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci [J].
Dale, James B. ;
Penfound, Thomas A. ;
Chiang, Edna Y. ;
Walton, William J. .
VACCINE, 2011, 29 (46) :8175-8178
[8]   emm typing and validation of provisional M types for group A streptococci [J].
Facklam, R ;
Beall, B ;
Efstratiou, A ;
Fischetti, V ;
Johnson, D ;
Kaplan, E ;
Kriz, P ;
Lovgren, M ;
Martin, D ;
Schwartz, B ;
Totolian, A ;
Bressen, D ;
Hollingshead, S ;
Rubin, F ;
Scott, J ;
Tyrrell, G .
EMERGING INFECTIOUS DISEASES, 1999, 5 (02) :247-253
[9]   STREPTOCOCCAL M-PROTEIN - MOLECULAR DESIGN AND BIOLOGICAL BEHAVIOR [J].
FISCHETTI, VA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (03) :285-314
[10]   HLA class II transgenic mice develop a safe and long lasting immune response against StreptInCor, an anti-group A streptococcus vaccine candidate [J].
Guerino, Milton T. ;
Postol, Edilberto ;
Demarchi, Lea M. F. ;
Martins, Carlo O. ;
Mundel, Luiz R. ;
Kalil, Jorge ;
Guilherme, Luiza .
VACCINE, 2011, 29 (46) :8250-8256